Nicholas Nystrom, PhD
Chief Technology Officer
Dr. Nicholas A. Nystrom is a science and technology expert responsible for planning, implementation, and operations across artificial intelligence (AI), machine learning (ML), computational science, data integration, and enterprise computing for Peptilogics. He is Principal Investigator for Peptilogics’ ARPA-H CATALYST (Computational ADME-Tox and Physiology Analysis for Safer Therapeutics) project, in which he leads development of DASH, an AI/ML platform for predicting ADME-Tox properties. He also leads real-time systems supporting clinical operations, technology partnerships, and is active in university relations.
Prior to joining Peptilogics, he was chief scientist at the Pittsburgh Supercomputing Center (PSC), a joint research center of Carnegie Mellon University and the University of Pittsburgh, where he architected the first AI+HPC supercomputer and scaled computer architectures to support AI for science. He also developed the compute and data architecture for the Human BioMolecular Atlas Program (HuBMAP) and AI/ML projects in oncology, chronic lung disease, and neuroscience.
Throughout his career, Dr. Nystrom has led R&D efforts in life sciences, advanced computing, computational chemistry, computer architecture, molecular dynamics, and performance engineering through collaborations with ARPA-H, NSF, NIH, DoD, DOE, DARPA, NASA, and industry partners.
Dr. Nystrom earned his PhD in chemistry, specializing in quantum chemistry, from the University of Pittsburgh, where he also completed graduate coursework in physics.